Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 3
1951 6
1952 2
1953 4
1954 5
1955 3
1956 3
1957 7
1958 1
1959 3
1960 4
1961 18
1962 16
1963 22
1964 25
1965 26
1966 33
1967 36
1968 29
1969 36
1970 46
1971 37
1972 44
1973 41
1974 48
1975 77
1976 62
1977 73
1978 96
1979 92
1980 87
1981 107
1982 109
1983 139
1984 128
1985 168
1986 180
1987 175
1988 209
1989 198
1990 214
1991 209
1992 211
1993 238
1994 240
1995 286
1996 285
1997 278
1998 348
1999 315
2000 358
2001 351
2002 309
2003 331
2004 419
2005 390
2006 392
2007 406
2008 450
2009 486
2010 500
2011 554
2012 585
2013 610
2014 596
2015 617
2016 646
2017 720
2018 689
2019 676
2020 747
2021 806
2022 821
2023 724
2024 289

Text availability

Article attribute

Article type

Publication date

Search Results

16,940 results

Results by year

Filters applied: . Clear all
Page 1
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience.
Nishie R, Tanaka T, Hirosuna K, Miyamoto S, Murakami H, Tsuchihashi H, Toji A, Ueda S, Morita N, Hashida S, Daimon A, Terada S, Maruoka H, Konishi H, Kogata Y, Taniguchi K, Komura K, Ohmichi M. Nishie R, et al. Among authors: tanaka t. J Clin Med. 2024 May 6;13(9):2718. doi: 10.3390/jcm13092718. J Clin Med. 2024. PMID: 38731247
Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.
Shindo T, Hashimoto K, Fujino K, Takahashi A, Hotta H, Maeda T, Kunishima Y, Fukuta F, Ito N, Wanifuchi A, Kato R, Okada M, Matsukawa M, Horita H, Takayanagi A, Kobayashi K, Tanaka T, Masumori N. Shindo T, et al. Among authors: tanaka t. World J Urol. 2024 May 9;42(1):307. doi: 10.1007/s00345-024-04952-z. World J Urol. 2024. PMID: 38722418
Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA.
Ono Y, Tezuka Y, Omata K, Morimoto R, Yamazaki Y, Oguro S, Takase K, Ito A, Yoshimi T, Kojima S, Ito S, Sasano H, Suzuki T, Tanaka T, Katagiri H, Satoh F. Ono Y, et al. Among authors: tanaka t. J Endocr Soc. 2024 Apr 20;8(6):bvae080. doi: 10.1210/jendso/bvae080. eCollection 2024 Apr 6. J Endocr Soc. 2024. PMID: 38715590 Free PMC article.
16,940 results
You have reached the last available page of results. Please see the User Guide for more information.